Results 41 to 50 of about 7,461,141 (296)

Centrality analysis of stage-III network.

, 2016
Centrality analysis of stage-III network.
Ashok Palaniappan (3165975), Satish Ramalingam (356175), Karthick Ramar (3165972)   +2 more
core   +1 more source

Accuracies generated by different models with different regressions from Group-III models, for vegetative reproductive stage.

, 2023
(a) Model-III-1: ΣVI-SUMs and time series CHM for vegetative reproductive stage, (b) Model-III-2: ΣVI-AUCs and time series CHM for vegetative reproductive stage, (c) Model-III-3: ΣVI-SUMs and CHM of DAP 117th for vegetative reproductive stage, (d) Model ...
Shakirah Nakasagga (14509781), Alper Adak (14509775), Sumantra Chatterjee (11130004), Seth C. Murray (276629), Scott Wilde (14509778)   +4 more
core   +1 more source

Computed tomography in stage III neuroblastoma [PDF]

American Journal of Roentgenology, 1985
This multicenter study was designed to determine if CT can assess operability in stage III neuroblastoma. Nineteen children (11 boys, eight girls), aged 2-51 months, considered to have, by conventional clinical and radiographic examinations, localized neuroblastoma that crossed the midline were examined by CT.
M I, Boechat, J, Ortega, A D, Hoffman, R H, Cleveland, H, Kangarloo, V, Gilsanz   +5 more
openaire   +2 more sources

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann, Maike Wellbrock, Javier Louro, Arndt Borkhardt, Martin Schrappe, Claudia Trübenbach, Desiree Grabow, Cécile M. Ronckers, Joachim Schüz   +8 more
wiley   +1 more source

Moduland decomposition of stage-III network.

, 2016
Moduland decomposition of stage-III network.
Ashok Palaniappan (3165975), Satish Ramalingam (356175), Karthick Ramar (3165972)   +2 more
core   +1 more source

Carlos III, n. 58 bis, diciembre 2005 [PDF]

, 2005
Revista mensual de la Universidad Carlos III de ...
Universidad Carlos III de Madrid
core   +1 more source

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

Frontiers in Oncology, 2021
BackgroundFor unresectable stage III non-small cell lung cancer (NSCLC), concurrent chemoradiotherapy is nowadays the standard treatment. Patients with advanced NSCLC harboring driver-gene mutations benefit from Tyrosine Kinase Inhibitors (TKIs) Therapy.
Ranpu Wu, Shaorong Yu, Jinjun Ye, Yimin Wang, Zhiting Zhao, Hongbing Liu, Hongbing Liu, Yong Song, Yong Song   +8 more
doaj   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source

Management of stage III non-small-cell lung cancer: rays of hope

Exploration of Targeted Anti-tumor Therapy
Lung cancer remains the most common cause of cancer death across the world. Non-small-cell lung cancer (NSCLC) represents the most frequent type of lung cancer and is frequently diagnosed at an advanced stage.
Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender   +3 more
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source